Panel Discussion | What Does the Future Hold for TMVR? Predictions for the Next 5 Years

Sunday, March 8, 2026

5:29 PM - 5:45 PM EST

Location: Jefferson

Moderator(s)

Sachin S. Goel, MD, FACC, FSCAI

Medical Director, Structural Heart Interventions
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
Jonathon Leipsic, MD, FRCPC

Professor of Radiology and Cardiology
St. Paul's Hospital
Vancouver, British Columbia, Canada

Disclosure(s): Heart Flow: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Panel Discussant(s)

Mayra E. Guerrero, MD, FACC, FSCAI

Professor of Medicine
Mayo Clinic Hospital
Rochester, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): QmedConsulting: Consulting Fees (e.g., advisory boards) (Ongoing)
Firas Zahr, MD

Director, Interventional Cardiology
OHSU

Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Pradeep Yadav, MD

Director of Structural Interventions
Piedmont Atlanta Hospital
Atlanta, Georgia, United States

Disclosure information not submitted.
Hussam Suradi, MD

Cath lab director
Rush University Medical Center
chicago, Illinois, United States

Disclosure(s): No financial relationships to disclose
James Stewart, MD

Structural Interventional Cardiologist
Piedmont Heart Institute

Disclosure(s): No financial relationships to disclose
Santiago Garcia, MD

Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
The Christ Hospital
Cincinnati, Ohio, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Sachin S. Goel, MD, FACC, FSCAI: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Jonathon Leipsic, MD, FRCPC: Heart Flow: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Mayra E. Guerrero, MD, FACC, FSCAI: No financial relationships to disclose

Michael H. Joner, MD: QmedConsulting: Consulting Fees (e.g., advisory boards) (Ongoing)

Firas Zahr, MD: Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Hussam Suradi, MD: No financial relationships to disclose

James Stewart, MD: No financial relationships to disclose

Santiago Garcia, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)